The National Institutes of Health (NIH) announced that the use of Paxlovid to treat Long Covid will be the first treatment to be studied by its $1 billion RECOVER Initiative. … Continue reading RECOVER Study of Paxlovid to Treat Long Covid Begins January 2023, Has Implications for ME/CFS